Mary’s Medicinals, a Denver-based marijuana business specializing in transdermal technology, has entered Oregon, growing its availability of topical cannabis products to four states nationwide.
Already sold in California, Colorado and Washington, Mary’s Medicinals is rolling out its line in Oregon gradually, starting with the adhesive transdermal patches through an official partnership with Oregrown. Self-proclaimed as “Oregon’s premier farm-to-table cannabis company,” Oregrown is manufacturing and distributing products created by Mary’s Medicinals — the first company to offer in its lineup cannabis compounds THCa (non-psychoactive tetrahydrocannabinolic acid) and CBN (cannabinol), according to a news release.
SPECIAL REPORT: CBD in Colorado. Learn about the cannabis plant compound cannabidiol, which has drawn hundreds of desperate families to Colorado, in This Denver Post series that was a 2015 Pulitzer finalist
Part 1: What’s on the market? Info about kief, BHO, water hash and more
Part 2: How should I smoke this shatter? There are many ways to consume concentrates
Part 3: Are concentrates right for me? What you need to know about potency, expected effects and more
“Our industry is helping a lot of people with cannabis medicine, but the delivery methods aren’t always convenient for patients. That’s why Mary’s developed the transdermal patch: so patients could have a long-lasting, accurate, clean and safe method of taking their cannabis-based medicine,” said Mary’s Medicinals CEO and founder Nicole Smith in a statement to The Cannabist.
What started as a medical-only line pioneering accurate cannabinoid dosing in alternative vehicles in 2013, Mary’s Medicinals chief scientist, Noel Palmer, has continued to develop different delivery methods with unique cannabinoid extractions said to have pain-relieving qualities. In 2014, the company took home a third-place award for its transdermal gel at the Washington Cannabis Cup. Other Mary’s Medicinals product offerings include a transdermal pen, capsules and topical compound — available medically and recreationally (except California) — plus a special line for pets.
The individually sold transdermal patches (10mg or 20mg) retail for $10-$16 (varies by dispensary) and are available in CBD (cannabidiol), THCa, CBN, CBD:THC 1:1 (Cannabidiol/Tetrahydrocannabinol), THC Indica and THC Sativa. Each 2-inch by 2-inch square is clinical-grade and latex-free, permeating the bloodstream for rapid action and lasting effect.
Outside of Oregrown’s Bend dispensary location, which will have recreational sales starting Oct. 1, a company representative said Mary’s Medicinals patches will be available to medical and recreational customers at additional locations throughout the state “within about a month.”
Cannabist Show interview with Mary’s Medicinals CEO Nicole Smith
(cue to the 19:20 mark):